Literature DB >> 3711300

Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis.

R M Genta, R W Douce, P D Walzer.   

Abstract

Parasite-specific humoral and cellular immune responses were evaluated in in nine immunosuppressed patients with Strongyloides stercoralis infection. Four patients had the disseminated form of the disease, and five had serious manifestations without evidence of hyperinfection. All patients had high levels of immunoglobulin G (IgG) antibodies directed against S. stercoralis larval antigens as detected by the enzyme-linked immunosorbent assay. Seven patients had both elevated total serum IgE and parasite-specific IgE antibodies detected by a modified radioimmunoassay. The hyperinfected patients differed significantly from the nonhyperinfected group in total and specific IgE levels and peripheral eosinophilia but not in specific IgG levels. None of the patients tested exhibited significant in vitro lymphoproliferative responses to parasite antigens. Our results indicated that the possibility of a protective role of IgE and eosinophils in strongyloidiasis deserves further investigation. In addition, we suggest that the enzyme-linked immunosorbent assay for specific IgG antibodies may have an important place in the diagnosis of strongyloidiasis in immunocompetent as well as in immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711300      PMCID: PMC268802          DOI: 10.1128/jcm.23.6.1099-1103.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Preparation of rabbit anti-IgE for use in radioimmunoassays of total IgE and specific IgE antibodies.

Authors:  W Y Lee; D C Heiner
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

2.  Host defense mechanisms against Trichinella spiralis infection in the mouse: eosinophil-mediated destruction of newborn larvae in vitro.

Authors:  J W Kazura; M Aikawa
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

3.  Strongyloides ratti: 1. parasitological observations on primary and secondary infections in the small intestine of rats.

Authors:  R Moqbel; D A Denham
Journal:  J Helminthol       Date:  1977       Impact factor: 2.170

4.  Fatal strongyloidiasis in patients receiving corticosteroids.

Authors:  T Cruz; G Reboucas; H Rocha
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

5.  Lack of immunoglobulin E response to longstanding strongyloidiasis.

Authors:  G V Gill; D R Bell; R Fifield
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

6.  Strongyloides stercoralis infection in former Far East prisoners of war.

Authors:  G V Gill; D R Bell
Journal:  Br Med J       Date:  1979-09-08

7.  Strongyloidiasis in Allied ex-prisoners of war in south-east Asia.

Authors:  D I Grove
Journal:  Br Med J       Date:  1980-03-01

8.  Strongyloides stercoralis hyperinfection masquerading as cerebral vasculitis.

Authors:  R M Wachter; A M Burke; R R MacGregor
Journal:  Arch Neurol       Date:  1984-11

Review 9.  Overwhelming strongyloidiasis: an unappreciated opportunistic infection.

Authors:  E B Scowden; W Schaffner; W J Stone
Journal:  Medicine (Baltimore)       Date:  1978-11       Impact factor: 1.889

10.  [Strongyloidiasis following kidney transplantation].

Authors:  J Briner; J Eckert; D Frei; F Largiadèr; U Binswanger; A Blumberg
Journal:  Schweiz Med Wochenschr       Date:  1978-10-21
View more
  12 in total

Review 1.  Dysregulation of strongyloidiasis: a new hypothesis.

Authors:  R M Genta
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

2.  Comparative evaluation of Strongyloides ratti and S. stercoralis larval antigen for diagnosis of strongyloidiasis in an endemic area of opisthorchiasis.

Authors:  Chatanun Eamudomkarn; Paiboon Sithithaworn; Jiraporn Sithithaworn; Sasithorn Kaewkes; Banchob Sripa; Makoto Itoh
Journal:  Parasitol Res       Date:  2015-04-17       Impact factor: 2.289

Review 3.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

4.  Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.

Authors:  Tatvam T Choksi; Gul Madison; Tawseef Dar; Mohammed Asif; Kevin Fleming; Leon Clarke; Mervyn Danilewitz; Randa Hennawy
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

5.  Demonstration and partial characterization of parasite-specific immunoglobulin A responses in human strongyloidiasis.

Authors:  R M Genta; D F Frei; M J Linke
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 6.  Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management.

Authors:  Sue Lim; Kevin Katz; Sigmund Krajden; Milan Fuksa; Jay S Keystone; Kevin C Kain
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

7.  Specific IgE responses in human strongyloidiasis.

Authors:  J McRury; I T De Messias; P D Walzer; T Huitger; R M Genta
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

8.  Identification of a 26-kDa protein fraction as an important antigen for application in the immunodiagnosis of strongyloidiasis.

Authors:  Adriana P Sudré; Ricardo C Siqueira; Magali G M Barreto; Regina H S Peralta; Heloisa W Macedo; José M Peralta
Journal:  Parasitol Res       Date:  2007-06-14       Impact factor: 2.289

9.  Endemic institutional strongyloidiasis in British Columbia.

Authors:  E M Proctor; H A Muth; D L Proudfoot; A B Allen; R Fisk; J Isaac-Renton; W A Black
Journal:  CMAJ       Date:  1987-06-01       Impact factor: 8.262

Review 10.  A fatal case of systemic strongyloidiasis and review of the literature.

Authors:  L H Hagelskjaer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.